Nyrada Inc Total Liabilities

Latest as of December 2025: AU$548.97K AUD ≈ $388.43K USD

Nyrada Inc total liabilities. Based on the latest financial reports, Nyrada Inc (NYR) has total liabilities worth AU$548.97K AUD (≈ $388.43K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NYR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nyrada Inc (2018–2025)

Total liabilities of Nyrada Inc from 2018 to 2025. This chart illustrates how Nyrada Inc's total liabilities have evolved over time, based on quarterly financial data.

Nyrada Inc Competitors by Total Liabilities

The table below lists competitors of Nyrada Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Delfingen PA:ALDEL	France	€215.02 Million
Cell Biotech Co. Ltd KQ:049960	Korea	₩7.46 Billion
Daehan Synthet KO:003830	Korea	₩127.57 Billion
Qualicorp Consultoria e Corretora de Seguros S.A SA:QUAL3	Brazil	R$2.08 Billion
Blue Cap AG XETRA:B7E	Germany	€112.79 Million
I-Tech ST:ITECH	Sweden	Skr28.66 Million
Summit State Bank NASDAQ:SSBI	USA	$858.43 Million
LK CHEM KQ:489500	Korea	₩6.53 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Nyrada Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NYR total asset value.

Liquidity & Leverage Metrics

Nyrada Inc Total Liabilities Ratios Explained

Nyrada Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	19.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nyrada Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nyrada Inc (2018–2025)

The table below shows the annual total liabilities of Nyrada Inc from 2018 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.72 Million ≈ $1.22 Million	+101.40%
2024-06-30	AU$855.63K ≈ $605.41K	-5.59%
2023-06-30	AU$906.28K ≈ $641.25K	+75.81%
2022-06-30	AU$515.48K ≈ $364.73K	-22.53%
2021-06-30	AU$665.38K ≈ $470.80K	-10.16%
2020-06-30	AU$740.67K ≈ $524.07K	-87.85%
2019-06-30	AU$6.10 Million ≈ $4.31 Million	+34.52%
2018-06-30	AU$4.53 Million ≈ $3.21 Million	--

About Nyrada Inc

AU:NYR Australia Biotechnology

Market Cap

$77.13 Million

AU$109.00 Million AUD

Market Cap Rank

#20009 Global

#659 in Australia

Share Price

AU$0.45

Change (1 day)

+2.30%

52-Week Range

AU$0.40 - AU$1.38

All Time High

AU$1.38